Evidence map›Paper›PMID 31684190›Full record

ArticleBiomolecules2019

Iman O Sherif, Nora H Al-Shaalan, Dina Sabry

Open access · goldAbstract read
In one paragraph

Article in Biomolecules, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Nephrotoxicity in cancer treatment: An update.Advances in cancer research · 2022
    Article
  12. Article
  13. Review
  14. Integrative cancer therapies
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Iman O SherifEmergency Hospital, Faculty of Medicine, Mansoura University, Mansoura 35516, Egypt. emyosh@yahoo.com.
Nora H Al-ShaalanChemistry Department, College of Science, Princess Nourah bint Abdulrahman University, Riyadh 11671, Saudi Arabia. nhalshaalan@pnu.edu.sa.
Dina SabryMedical Biochemistry and Molecular Biology Department, Faculty of Medicine, Cairo University, Cairo 11562, Egypt. dinasabry@kasralainy.edu.eg.
Cairo University · EGMansoura University Hospital · EGPrincess Nourah bint Abdulrahman University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Renal injury induced by the chemotherapeutic agent methotrexate (MTX) is a serious adverse effect that has limited its use in the treatment of various clinical conditions. The antioxidant activity of

Indexed as

AnimalsGinkgo bilobaGinkgo ExtractHumansKidneyKidney DiseasesMaleMethotrexatePhosphatidylinositol 3-KinasesPlant ExtractsProto-Oncogene Proteins c-aktRatsRats, Sprague-DawleyRNA, Long NoncodingSignal TransductionTOR Serine-Threonine KinasesGinkgo biloba extractGinkgo ExtractMALAT1 long noncoding RNA, ratMethotrexatePhosphatidylinositol 3-KinasesPlant ExtractsProto-Oncogene Proteins c-aktRNA, Long NoncodingTOR Serine-Threonine KinasesGinkgo biloba extractMethotrexatenephrotoxicityPI3K/Akt/mTOR

Identifiers

PMID31684190
PMCPMC6920877
OpenAlexW2982820736

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.